Seattle Startup RevealDx Raises $4.25M to Improve Lung Cancer Diagnosis with AI Technology

Seattle startup RevealDx raised $4.25 million to enhance lung cancer diagnosis using machine learning to analyze chest CT scans, aiming to accelerate diagnosis and reduce false positives. The company, formerly Mindshare Medical, is expanding in Europe and pursuing FDA approval in the U.S.

RRevealDx CClario Medical Imaging